Analysts have recently evaluated Halozyme Therapeutics and provided 12-month price targets. The average target is $66.78, accompanied by a high estimate of $75.00 and a low estimate of $53.00. Holding ...

Fallout is arguably the biggest IP in Xbox’s portfolio right now, with Halo, Gears of War, and The Elder Scrolls on ice. With ...

Looking for a guilt-free dessert? These seven low-calorie ice creams taste amazing while keeping your calorie count in check.

Q4 2024 Earnings Call Transcript February 18, 2025 Halozyme Therapeutics, Inc. beats earnings expectations. Reported EPS is ...

Halozyme Therapeutics Inc (HALO) surpasses $1 billion in revenue for the first time, with robust growth expected to continue into 2025.

Halozyme Therapeutics' record-breaking 2024 revenue exceeded $1B, with strong 2025 growth projections led by DARZALEX & VYVGART.

While the top- and bottom-line numbers for Halozyme Therapeutics (HALO) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key ...

If you've ever wondered how Saber Interactive ended up handling the remaster of one of the biggest shooters of all time, well ...

Working on Halo for free--and a contract mistake on Xbox's part--helped Saber Interactive get off the ground.